Evolution of the Average Target: Genpact Limited

Evolution of the Target Price: Genpact Limited

Changes in Analyst Recommendations: Genpact Limited

94480e2f24da151814bf9.FPA1wUKzldJIFHnItSHKcQpcmAo1-eW2hMdpcmB_dCk.S8Fyoy-Bx6QSJhGyhxWrCWs-_VN7s6GA6J0fJTMuM0t5sxj3B-TcsxxYEg~11ca6c012182ec0c2b8295bcd3f0fe2e
05-11 Mizuho Securities Adjusts Genpact Price Target to $39 From $49, Maintains Neutral Rating MT
12-12 Susquehanna Initiates Genpact With Neutral Rating, $50 Price Target MT
07/08/25 Genpact Q2 revenue, adjusted profit beats estimates RE
27/06/25 TD Cowen Raises Price Target on Genpact to $55 From $53, Maintains Buy Rating MT
10/02/25 Analyst recommendations: Drax, AstraZeneca, HSBC, Broadcom, Tesla... Zonebourse
10/02/25 Analyst recommendations: Aspen, Amazon, Mattel, Broadcom, Tesla… Zonebourse
07/02/25 Deutsche Bank Adjusts Genpact Price Target to $55 From $48, Maintains Hold Rating MT
07/02/25 TD Cowen Upgrades Genpact to Buy From Hold, Adjusts Price Target to $60 From $45 MT
21/01/25 Jefferies Upgrades Genpact to Buy From Hold, Adjusts Price Target to $55 From $44 MT
21/01/25 Analyst recommendations: Apple, On Holding, Amazon, Palo Alto Networks, Tesla... Zonebourse
11/11/24 Deutsche Bank Adjusts Genpact Price Target to $48 From $37, Maintains Hold Rating MT
11/11/24 Analyst recommendations: Moderna, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Arista Networks... Zonebourse
17/07/24 JPMorgan Upgrades Genpact to Neutral From Underweight, Price Target is $40 MT
17/07/24 Analyst recommendations: American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly... Zonebourse
30/01/24 Mizuho Securities Initiates Genpact With Neutral Rating, Price Target is $40 MT
17/01/24 Citigroup Adjusts Price Target on Genpact to $36 From $35, Maintains Neutral Rating MT
15/12/23 Baird Downgrades Genpact to Neutral From Outperform, Price Target is $38 MT
13/11/23 Wedbush Lowers Genpact's PT to $35 From $45 After Weaker-Than-Expected Q3 Results, Resets Full-Year 2023 Guidance; Keeps Neutral Rating MT
22/08/23 JPMorgan Downgrades Genpact to Underweight From Neutral, Price Target is $40 MT
11/08/23 Needham Adjusts Genpact Price Target to $50 From $56, Maintains Buy Rating MT
10/08/23 Deutsche Bank Adjusts Genpact Price Target to $37 From $48, Maintains Hold Rating MT
10/08/23 BMO Capital Adjusts Price Target on Genpact to $41 From $46, Maintains Market Perform Rating MT
18/07/23 Citigroup Downgrades Genpact to Neutral From Buy, Adjusts Price Target to $42 From $46 MT
11/05/23 JPMorgan Cuts Genpact's Price Target to $46 From $53, Neutral Rating Kept MT
11/05/23 TD Cowen Adjusts Price Target on Genpact to $44 From $48, Maintains Market Perform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+45.89%
+15.06%
+13.22%
+23.7%
+16.76%
+0.5%
+5.33%
+3.98%
+16.48%
Average +15.66%
Weighted average by Cap. +14.73%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
29.10USD
Average target price
42.45USD
Spread / Average Target
+45.89%
High Price Target
58.00USD
Spread / Highest target
+99.31%
Low Price Target
32.00USD
Spread / Lowest Target
+9.97%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Mizuho Securities
Susquehanna
TD Cowen
Deutsche Bank Securities
Jefferies & Co.
Citigroup
Baird
Wedbush
JPMorgan Chase
Needham & Co.
BMO Capital
Cowen
J.P. Morgan Chase
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
29.10USD
Average target price
42.45USD
Spread / Average Target
+45.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. G Stock
  4. Consensus Genpact Limited